Roble Belko & Company’s Zoetis ZTS Stock Holding History

Roble Belko & Company’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-99	Closed	-$5K	–	353
2017 Q1	$5K	Hold	99	–	–	﹤0.01%	264
2016 Q4	$5K	Buy	+99	New	+$5.03K	﹤0.01%	278

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Roble Belko & Company's ZTS Position: Q2 2017 in Review

Roble Belko & Company sold out of Zoetis (ZTS) in Q2 2017, closing a stake of 99 shares — an estimated $5K sold.

Roble Belko & Company first reported a position in ZTS in Q4 2016 and held it in 2 quarters. The position peaked at $5K in Q1 2017. 756 funds tracked by Wall St. Rank hold ZTS as of Q2 2017.

Roble Belko & Company reported no remaining Zoetis position as of Q2 2017 after selling out during the quarter.
Roble Belko & Company sold 99 Zoetis shares in Q2 2017, an estimated $5K.
Roble Belko & Company first reported a position in Zoetis in Q4 2016 and held it in 2 quarters.
Roble Belko & Company's Zoetis position peaked at $5K in Q1 2017.
756 funds tracked by Wall St. Rank held Zoetis as of Q2 2017.

Based on Roble Belko & Company's 13F filing for Q2 2017, filed 11 Aug 2017.